Detection Sensitivity
Ability to extract information
relevant to embryo viability.
Functional Stability
Probes and biosensors remain functional for extended culture periods (48–120 hours).
Real-Time Response
Data updates every 1–5 minutes, ensuring continuous monitoring for clinics and patients.
IoT communication
End-to-end encryption for IoT communication and blockchain storage for security and efficiency.
Edge Computing in Peptivue’s Ecosystem
Edge computing aligns with Peptivue’s goals of providing real-time, non-invasive embryo health monitoring while ensuring data security and efficiency. It complements IoT and blockchain technologies, creating a seamless ecosystem for clinics and patients.
Real-Time Embryo Monitoring
Edge devices in the smart incubator can process data from biosensors locally, enabling immediate alerts for clinicians. This reduces reliance on cloud servers and ensures faster decision-making.
Data Security
Sensitive embryo health data can be processed and stored locally at the edge, reducing risks associated with cloud transmission.
IoT Integration
Edge computing enhances IoT devices by enabling faster communication between biosensors, the incubator, and the blockchain system.
Scalability
Clinics can deploy edge computing-enabled incubators without relying on high-bandwidth cloud infrastructure, making the system more accessible globally.
Our Solution
Peptivue is more than a product—it’s a movement to transform how fertility clinics assess embryo health. By providing a non-invasive, high-tech solution, we empower clinicians, inspire patients, and revolutionize an industry.
Join us on this journey to shape the future of reproductive medicine.
Blockchain Technology
Experience accurate, non-invasive fertility assessments like never before.
Non-Invasive Testing
Innovative Non-Invasive Testing for IVF
IoT-enabled Biosensor
Leverage cutting-edge tools to make informed reproductive choices.
The Problem We are Solving
Here are the existing challenges to the IVF industry.
Invasive Biopsies
Traditional embryo health assessment methods like PGT-A require invasive biopsies, increasing risks of damage.
Lack of capability to monitor biomarkers
Current incubators focus solely on environmental control but lack capability to monitor biomarkers for embryo viability.
Key Performance Metrics
This section highlights upcoming events and activities, offering an overview of exciting opportunities to engage with the community and participate in meaningful experiences.
Are you interested in investing?
PeptiVue is transforming fertility care with a non-invasive, high-tech solution that delivers unmatched accuracy in assessing embryo health. Seamlessly integrating into clinic workflows, our platform empowers clinicians to make more confident decisions while providing peace of mind to patients. As demand for advanced reproductive solutions grows, PeptiVue stands at the forefront—driving better outcomes, streamlining operations, and setting a new standard in embryo evaluation.
Contact us to learn more about how you can invest in the future of reproductive health.
Are you interested in investing?
PeptiVue is transforming fertility care with a non-invasive, high-tech solution that delivers unmatched accuracy in assessing embryo health. Seamlessly integrating into clinic workflows, our platform empowers clinicians to make more confident decisions while providing peace of mind to patients. As demand for advanced reproductive solutions grows, PeptiVue stands at the forefront—driving better outcomes, streamlining operations, and setting a new standard in embryo evaluation.